Lawsuit Overview
December 13, 2013 (Shareholders Foundation) - An investor who currently holds NASDAQ:OREX shares, filed a lawsuit against directors of Orexigen Therapeutics, Inc. (NASDAQ:OREX) over alleged breaches of fiduciary duties. According to the complaint the plaintiff alleges that the defendants breached their fiduciary duties by awarding themselves in excess of the 1.5million annual stock ...
You must register (for free) or login to view the entire case.